Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.
Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.
Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.
Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.
This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.
Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.
Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.
Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.
Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.
Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.
Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.
Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.
Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.
Cardiovascular diseases are the number one cause of deaths globally. Tet methylcytosine dioxygenase 2 (TET2)-mediated hematopoiesis has been implicated in accelerating heart failure. Here is the latest research on cardiovascular diseases and TET2.
Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.
Blood pressure is tightly regulated by blood vessel radius, which is established by hormones and/or peptides binding to GPCRs (G-protein-coupled receptors). Discover the latest research on GPCRs in blood pressure regulation here
HF-pEF is associated with left ventricular diastolic dysfunction and concentric left ventricular hypertrophy and has significant mortality and morbidity. The heterogeneity of the disease has resulted in the failure of any drugs for the treatment of HF-pEF. Here are the latest discoveries pertaining to this disease.
Heart failure with reduced ejection fraction (HF-rEF) is responsible for high costs and increased rates of hospital admissions along with high mortality and morbidity risks. Only treatment for HF-rEF has been shown to be efficacious compared to HF-pEF which currently has no useful treatment options. Here is the latest research on HF-rEF.
Inotropic agents alter the force or energy of muscular contractions. Negatively inotropic agents weaken the force of muscular contractions. Positively inotropic agents increase the strength of muscular contraction. Inotropic agents are used in hospitalized patients with acute decompensated heart failure, with reduced left ventricular ejection fraction and with signs of end-organ dysfunction in the setting of a low cardiac output, or with severe systolic heart failure awaiting heart transplant to maintain hemodynamic stability or as a bridge to decision. Discover the latest research on inotrpic agents and heart diseases here.
This feed focuses on Membrane Transport proteins and their dysfunction which can lead to heart disease. Discover the latest research on Membrane Transport in Heart Failure.
Metabolic syndrome is characterized by obesity, insulin resistance, dyslipidemia and hypertension. It significantly increases the risk for cardiovascular and disease and type 2 diabetes. Increasing prevalence has been associated with the increasing rates of obesity worldwide. Here is the latest research on the metabolic syndrome.
The constellation of dyslipidemia (hypertriglyceridemia and low levels of high-density lipoprotein cholesterol), elevated blood pressure, impaired glucose tolerance, and central obesity is now classified as metabolic syndrome, also called syndrome X. It is considered to be a precursor of cardiovascular disease. Discover the latest research on metabolic syndrome and cardiovascular disease here.
Mitochondrial dysfunction has wide-ranging effects on cellular function and has been implicated in the pathogenesis of a variety of cardiovascular diseases.
Myocardial rupture is a catastrophic complication of acute myocardial infarction that usually results in sudden death. Here is the latest research.
Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.
Myocardial infarctions occur when blood flow to a part of the heart decreases or stops. Here is the latest research on factors and mechanisms that modulate the risk of myocardial infarctions.
Myocarditis is an acute or chronic inflammatory disease of the myocardium which can be viral, postinfectious immune or primarily organ-specific autoimmune. Discover the latest research on myocarditis here.
The activation of neurohumoral compensatory mechanisms is a common physiological phenomenon in heart failure in order to make up for a failing heart, which will usually have a deteriorating effect on overall health condition. Discover the latest research on Neurohumoral Compensatory Mechanisms here.
Non-bacterial thrombotic endocarditis is characterized by the presence of non-infected vegetation on the heart valves, namely aortic and mitral. A higher rate of these vegetation are see in cancer patients. Here is the latest research on non-bacterial thrombotic endocarditis.
Rheumatic heart disease, the sequel of acute rheumatic fever, continues to be a common health problem in the developing world, causing morbidity and mortality among both children and adults. Discover the latest research on rheumatic heart disease here.
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are novel anti-diabetic drugs that lowers blood glucose. This feed focuses on the role of SGLT2i in diabetes and reducing heart failure.
Spontaneous coronary artery dissection is a rare cause of acute coronary syndrome and sudden cardiac death. Here is the latest research.
Statins or HMG-CoA reductase inhibitors, are used clinically to lower cholesterol levels and have been associated with decreased risk of heart disease. Discover the latest research on Statin Medications & Heart Disease here.
Stem cells have the therapeutic potential for cardiac repair and regeneration after myocardial infarction. Discover the latest research in Stem Cells In Cardiac Repair here.
Subacute bacterial endocarditis (SBE) is an infection of the heart involving damaged valves or endothelium. Discover the latest research on SBE here.
Valvular heart disease causes significant burden within the realm of cardiovascular diseases and is increasing in prevalence, especially that of aortic valve insufficiency. Rheumatic fever causing valvular diseases has decreased incidence in industrialized countries. Discover the latest research on valvular disease here.
Vascular disease prevention is important to reduce the incidence of cardiovascular events and the high morbidity and mortality. Here is the latest research.